Liquid reservoir transdermal patch for the administration of ket

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424449, A61K 3140, A61K 970

Patent

active

055917674

ABSTRACT:
The invention is directed to a patch for the transdermal delivery of the racemic form or the active enantiomer of the analgesic ketorolac. The transdermal patch is capable of delivering therapeutically effective doses of the drug for a period of 12 hours or more. The patch is capable of delivering the racemate of ketorolac at a flux rate of 40 .mu.g/cm.sup.2 .multidot.hr or more, and of the active enantiomer at a flux rate of 20 .mu.g/cm.sup.2 .multidot.hr or more.

REFERENCES:
patent: 3797494 (1974-03-01), Zaffaroni
patent: 4031894 (1977-06-01), Urquhart et al.
patent: 4089969 (1978-05-01), Muchowski et al.
patent: 4460372 (1984-07-01), Campbell et al.
patent: 4588580 (1986-05-01), Gale et al.
patent: 4615699 (1986-10-01), Gale et al.
patent: 4818541 (1989-04-01), Sanderson
patent: 4839174 (1989-06-01), Baker et al.
patent: 4906463 (1990-03-01), Cleary et al.
patent: 4908027 (1990-03-01), Enscore et al.
patent: 4910205 (1990-03-01), Kogan et al.
patent: 4915950 (1990-04-01), Miranda et al.
patent: 4956181 (1990-09-01), Bayer et al.
patent: 4992445 (1991-02-01), Lawter et al.
patent: 5008110 (1991-04-01), Benecke et al.
patent: 5049386 (1991-09-01), Eppstein et al.
patent: 5069909 (1991-12-01), Sharma et al.
patent: 5091182 (1992-02-01), Ong et al.
patent: 5114946 (1992-05-01), Lawter et al.
patent: 5124157 (1992-06-01), Colley et al.
patent: 5519046 (1996-05-01), Noda et al.
Baker, R. W. Controlled Release of Biologically Active Agents, John Wiley & Sons, NY pp. 4-10 (1987).
Jamali et al. J. of Pharmaceutical Sciences 789 695-714 (1989).
Campbell, D. B. European J. of Drug Metabolism and Pharmacokinetics15 109-125 (1990).
Guzman, et al. J. Med. Chem. 29 589-591 (1986).
Mroszczak et al. Clin. Pharmacology & Therapeutics49 126 (1991).
Stinson C&EN46-79 (Sep. 28, 1992).
Yu, et al., "Percutanteous Absorption of Nicardipine and Ketorolac in Rehsus Monkeys," Pharmaceutical Research, vol. 5, No. 7, 1988, pp. 457-462.
Greenwald, "Ketorolac: An Innovative Non-Steroidal Analgesic," Drugs of Today, vol. 28, No. 1, 1992, pp. 41-61.
Pfister, et al., "Permeation Enhancers Compatible with Transdermal Drug Delivery Systems--Part I . . . ," Phar. Tech. Sep. 1990, pp. 132-140.
Brocks et al., Medline AbstractNo. 93092511, 1992.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Liquid reservoir transdermal patch for the administration of ket does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liquid reservoir transdermal patch for the administration of ket, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid reservoir transdermal patch for the administration of ket will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1764677

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.